Portfolio Companies

Portfolio Companies


Current Sector News Items

 
 
Wednesday, 07 March 2012
Galen Partners Leads $11.2M Round for Quotient Biodiagnostics
 
Tuesday, 27 September 2011
Acura Pharmaceuticals Awarded Key U.S. Patent
 
Thursday, 28 July 2011
David F. Azad Appointed to Board of Directors
 
Friday, 08 July 2011
FDA Approves Tamper-Resistant Pain Drug, Oxecta
 
Tuesday, 08 March 2011
Cambrooke Foods, Inc. Announces Series A Financing, Led by Galen Partners
 
Tuesday, 02 November 2010
Diclofenac Potassium Powder Well Tolerated, Provides Rapid Pain Relief for Migraine: Presented at CONy
 
 

Galen focuses on companies with proprietary products and services. We focus on companies within three key areas of healthcare: – medical devices & technology, specialty pharmaceuticals, and information technology & services.


Specialty Pharmaceuticals

Past investments
Dow Pharmaceutical Sciences LLC Dow Pharmaceutical Sciences LLC  (Private)
Petaluma, CA – Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market.
 
JDS Pharmaceuticals, LLC JDS Pharmaceuticals, LLC  (Acquired by Noven - NASDAQ: NOVN)
New York, NY – Developer, manufacturer and marketer of drugs focused on disorders of the central nervous system.
 
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.  (NASDAQ: TARO)
Hawthorne, NY – Manufacturer and developer of generic drugs and pharmaceutical components.